Canada markets closed

Integra LifeSciences Holdings Corporation (IART)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
55.00+0.97 (+1.80%)
At close: 04:00PM EDT
55.00 0.00 (0.00%)
After hours: 04:05PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 4.53B
Enterprise Value 5.77B
Trailing P/E 29.60
Forward P/E 16.53
PEG Ratio (5 yr expected) 1.38
Price/Sales (ttm)2.98
Price/Book (mrq)2.80
Enterprise Value/Revenue 3.70
Enterprise Value/EBITDA 16.20

Trading Information

Stock Price History

Beta (5Y Monthly) 1.10
52-Week Change 3-20.24%
S&P500 52-Week Change 3-11.93%
52 Week High 376.70
52 Week Low 353.57
50-Day Moving Average 358.95
200-Day Moving Average 364.82

Share Statistics

Avg Vol (3 month) 3451.37k
Avg Vol (10 day) 3701.53k
Shares Outstanding 583.14M
Implied Shares Outstanding 6N/A
Float 872.11M
% Held by Insiders 113.08%
% Held by Institutions 192.32%
Shares Short (Jun 14, 2022) 43.95M
Short Ratio (Jun 14, 2022) 411.21
Short % of Float (Jun 14, 2022) 46.33%
Short % of Shares Outstanding (Jun 14, 2022) 44.75%
Shares Short (prior month May 12, 2022) 44.14M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 22:1
Last Split Date 3Jan 03, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin 10.04%
Operating Margin (ttm)18.40%

Management Effectiveness

Return on Assets (ttm)4.84%
Return on Equity (ttm)9.96%

Income Statement

Revenue (ttm)1.56B
Revenue Per Share (ttm)18.45
Quarterly Revenue Growth (yoy)4.60%
Gross Profit (ttm)976.97M
EBITDA 407.22M
Net Income Avi to Common (ttm)156.58M
Diluted EPS (ttm)1.87
Quarterly Earnings Growth (yoy)-27.50%

Balance Sheet

Total Cash (mrq)407.09M
Total Cash Per Share (mrq)4.9
Total Debt (mrq)1.66B
Total Debt/Equity (mrq)102.93
Current Ratio (mrq)3.38
Book Value Per Share (mrq)19.43

Cash Flow Statement

Operating Cash Flow (ttm)287.69M
Levered Free Cash Flow (ttm)256.13M